Meta-analysis | N trials | N quality components | Effect size | Favours homoeopathy | Significant? | ||
---|---|---|---|---|---|---|---|
Statistic | Metric | Estimate (95% confidence intervaI) | |||||
All trials with extractable data for meta-analysis | |||||||
 Linde (1997) [6] | 89 | 0 | Random effects | OR | 2.45 (2.05–2.93) |  > 1 | Yes |
 Linde (1998) [7] | 18 | 0 | Fixed effects | RR | 1.66 (1.20–2.28) |  > 1 | Yes |
 Linde (1998) [7] | 18 | 0 | Fixed effects | OR | 2.62 |  > 1 | Yes |
 Cucherat (2000) [8] | 17a | 0b | Not applicable |  | p = 0.000036 | NA | Yes |
 Mathie (2014) [10] | 22 | 0c | Random effects | OR | 1.53 (1.22–1.91) |  > 1 | Yes |
 Mathie (2017) [11] | 54 | 0c | Random effects | SMD | 0.33 (0.21–0.44) |  > 0 | Yes |
Sample restriction to high-quality trials | |||||||
 Linde (1997) [6] | 26 | 7 | Random effects | OR | 1.66 (1.33–2.08) |  > 1 | Yes |
26 | 7 | Meta regression | OR | 1.72 (1.28–2.31) |  > 1 | Yes | |
 Shang (2005)/Lüdtke (2008) [32] | 21 | 3 | Random effects | OR | 0.76 (0.59–0.99) |  < 1 | Yes |
 Mathie (2014) [10] | 3 | 7 | Random effects | OR | 1.98 (1.16–3.38) |  > 1 | Yes |
 Mathie (2017) [11] | 3 | 7 | Random effects | SMD | 0.18 (− 0.09 to + 0.46) |  > 0 | No |